Brand Name | Status | Last Update |
---|---|---|
amlodipine and valsartan | ANDA | 2023-12-14 |
amlodipine besylate and valsartan | ANDA | 2014-12-16 |
amlodipine, valsartan and hydrochlorothiazide | ANDA | 2023-12-14 |
amlodipine, valsartan, hydrochlorothiazide | ANDA | 2022-09-30 |
clopidogrel | ANDA | 2021-08-23 |
diovan | New Drug Application | 2023-07-11 |
diovan hct | New Drug Application | 2023-07-11 |
exforge | New Drug Application | 2023-07-13 |
exforge hct | New Drug Application | 2023-07-13 |
valsartan | ANDA | 2023-08-07 |
Expiration | Code | ||
---|---|---|---|
VALSARTAN, DIOVAN, NOVARTIS | |||
2024-04-19 | NPP | ||
SACUBITRIL / VALSARTAN, ENTRESTO, NOVARTIS PHARMS CORP | |||
2024-02-16 | M-82 | ||
2023-04-01 | PED |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Sacubitril / Valsartan, Entresto, Novartis Pharms Corp | |||
11058667 | 2036-05-09 | U-3170 | |
9517226 | 2033-08-22 | U-3084 | |
9937143 | 2033-08-22 | U-3084 | |
11135192 | 2033-08-22 | U-3084 | |
8877938 | 2027-05-27 | DS, DP | |
9388134 | 2026-11-08 | U-1723 | |
8101659 | 2025-01-15 | DP | |
7468390 | 2023-11-27 | DP | |
8404744 | 2023-01-14 | DP | |
8796331 | 2023-01-14 | U-1723 | |
Nebivolol Hydrochloride / Valsartan, Byvalson, Abbvie | |||
7838552 | 2027-10-04 | U-185 | |
7803838 | 2026-08-29 | DP | |
Aliskiren Hemifumarate / Valsartan, Valturna, Novartis | |||
8168616 | 2026-07-03 | DP | |
Amlodipine Besylate / Hydrochlorothiazide / Valsartan, Exforge Hct, Novartis | |||
8101599 | 2023-05-16 | DP | |
8475839 | 2023-05-16 | DP |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | 16 | 13 | 75 | 89 | 12 | 203 |
Heart failure | D006333 | HP_0001635 | I50 | 3 | 15 | 16 | 40 | 30 | 101 |
Healthy volunteers/patients | — | — | — | 22 | 1 | — | 1 | 3 | 27 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 4 | 2 | 3 | 11 | 2 | 21 |
Essential hypertension | D000075222 | — | I10 | — | 6 | 10 | 5 | 1 | 21 |
Chronic renal insufficiency | D051436 | — | N18 | 2 | 2 | 2 | 6 | 1 | 12 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | 2 | 5 | 3 | 1 | 10 |
Diabetic nephropathies | D003928 | EFO_0000401 | — | — | 2 | — | 6 | 1 | 9 |
Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | — | 1 | 3 | 4 | 8 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | 4 | 3 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | 7 | — | 3 | — | 1 | 11 |
Hypercholesterolemia | D006937 | HP_0003124 | — | — | — | 4 | — | 1 | 5 |
Hypertrophic cardiomyopathy | D002312 | EFO_0000538 | I42.1 | — | 4 | 1 | — | — | 4 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | 1 | 1 | — | 2 | 4 |
Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | 2 | — | 1 | 3 |
St elevation myocardial infarction | D000072657 | — | — | — | — | 2 | — | — | 2 |
Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | 1 | — | — | 2 |
Hyperkalemia | D006947 | HP_0002153 | E87.5 | — | — | 1 | — | 1 | 2 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | — | 1 | — | — | 1 |
Pneumonia | D011014 | EFO_0003106 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atrial remodeling | D064752 | — | — | — | 1 | — | — | 1 | 2 |
Pharmacokinetics | D010599 | — | — | 1 | 1 | — | — | — | 2 |
Pulmonary arterial hypertension | D000081029 | — | — | 1 | 1 | — | — | — | 2 |
Nephrotic syndrome | D009404 | EFO_0004255 | N04 | 1 | 1 | — | — | — | 2 |
Myositis | D009220 | EFO_0000783 | G72.49 | — | 1 | — | — | — | 1 |
Fibrosis | D005355 | — | — | — | 1 | — | — | — | 1 |
Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | 1 | — | — | — | 1 |
Metabolism | D008660 | GO_0008152 | — | — | 1 | — | — | — | 1 |
Energy metabolism | D004734 | — | — | — | 1 | — | — | — | 1 |
Arthritis | D001168 | HP_0001369 | M05-M14 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Iga vasculitis | D011695 | EFO_1000965 | D69.0 | 1 | — | — | — | — | 1 |
Magnetic resonance imaging | D008279 | — | — | 1 | — | — | — | — | 1 |
Oral administration | D000284 | — | — | 1 | — | — | — | — | 1 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | — | — | 1 |
Papillary thyroid cancer | D000077273 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Frailty | D000073496 | — | R53.1 | — | — | — | — | 1 | 1 |
Hematopoietic stem cell transplantation | D018380 | — | — | — | — | — | — | 1 | 1 |
Morbid obesity | D009767 | EFO_0001074 | — | — | — | — | — | 1 | 1 |
Hiv | D006678 | — | O98.7 | — | — | — | — | 1 | 1 |
Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | — | — | 1 | 1 |
Aging | D000375 | GO_0007568 | R41.81 | — | — | — | — | 1 | 1 |
Orthostatic hypotension | D007024 | — | I95.1 | — | — | — | — | 1 | 1 |
Insulin resistance | D007333 | HP_0000855 | E88.819 | — | — | — | — | 1 | 1 |
Microvascular angina | D017566 | — | — | — | — | — | — | 1 | 1 |
Transient ischemic attack | D002546 | EFO_0003764 | G45.9 | — | — | — | — | 1 | 1 |
Drug common name | Valsartan |
INN | valsartan |
Description | Valsartan is a monocarboxylic acid amide consisting of L-valine in which the amino hydrogens have been replaced by a pentanoyl and a [2'-(1H-tetrazol-5-yl)biphenyl]-4-yl]methyl group. It exhibits antihypertensive activity. It has a role as an antihypertensive agent, an angiotensin receptor antagonist, a xenobiotic and an environmental contaminant. It is a biphenylyltetrazole, a monocarboxylic acid amide and a monocarboxylic acid. |
Classification | Small molecule |
Drug class | angiotensin II receptor antagonists |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C |
PDB | — |
CAS-ID | 137862-53-4 |
RxCUI | — |
ChEMBL ID | CHEMBL1069 |
ChEBI ID | 9927 |
PubChem CID | 60846 |
DrugBank | DB00177 |
UNII ID | 80M03YXJ7I (ChemIDplus, GSRS) |